Mobilizing angel investment to support impact startups
Leodicum aspires to create a better future for our children. We make impact innovation possible by building bridges between business angels and startups driven by the same passion to leverage technology to achieve social and environmental good.
We leverage our global network to identify the most promising impact start-ups and the outstanding founders behind them.
We accelerate change by providing founders at the earliest stage of their journey with access to expertise, experience and capital from a network of mission-aligned entrepreneurs and business angels.
Our thesis
We will leave a better world to our children. The world is at a critical juncture. Climate change, social inequality, and the scarcity of natural resources are growing challenges that require urgent solutions. It is our responsibility to do good and deliver innovations that positively impact society and the environment.
We believe in technology innovation. We are at a pivotal moment in technology innovation. Agritech, edutech, biotech, healthtech, medtech, social tech, energytech, cleantech… technology is reshaping every industry. Artificial Intelligence accelerates this transition. Technology stands to solve complex problems on a global scale.
We believe innovation comes with a responsibility to do good. With great power comes great responsibility. Technology innovation must be done right and deliver a positive impact. We support technology innovation defining a future that is sustainable, equitable, and resilient. The technologies we create today will define the world our children inherit tomorrow.
We believe startups are the key to change. Startups challenge the status quo. They push boundaries. They make things happen. Impact startups are more than just trendsetters, they are instrumental in building a better future.
We believe in the power of impact investment at the earliest stage. Impact innovation is hard. By supporting entrepreneurs and founders from the very beginning, early stage impact investment garantes that innovation is done right from day one, enabling innovative, scalable solutions that will lead to a better world for all.
Portfolio
Signatur Biosciences (SigBio) makes precision diagnostics accessible to all, starting with breast cancer prognosis. Its molecular technology makes diagnosing complex diseases simple. No need for laborious tests and expensive machines, Signatur Biosciences kits bring molecular intelligence to widely accessible PCR equipment. SigBio aims to make precision oncology more accessible by enabling hospitals and labs to run high-quality genomic tests locally rather than relying on centralized testing providers.
Dune Health is building a new kind of clinic that turns data from medical-grade wearables into personalized treatment plans delivered by doctors and AI. By combining wearable data, automated care protocols, and continuous AI coaching, Dune helps physicians diagnose, treat, and monitor chronic conditions like sleep apnea, hypertension, and metabolic disorders at scale. Dune’s goal is to create a scalable healthcare model that delivers higher-quality, personalized care to millions of patients.
Caremaze is an AI platform that automates care coordination workflows for healthcare organizations. Its AI agents perform tasks such as finding providers, calling clinics, and booking patient appointments—work that is traditionally done manually by care coordinators—allowing healthcare teams to handle more patients with less administrative effort. By automating these processes, Caremaze helps hospitals and care teams improve efficiency, reduce costs, and ensure patients get the right care faster.
neuroClues is a MedTech company developing a portable, high-precision eye-tracking device that helps clinicians objectively measure eye movements to detect and monitor neurological disorders. By turning subtle eye movement patterns into quantifiable biomarkers, the system supports diagnosis, prognosis, and treatment monitoring for conditions such as Parkinson’s disease, multiple sclerosis, concussion, and Alzheimer’s. Its goal is to bring fast, non-invasive brain health assessment directly into routine clinical care—acting as a “stethoscope for the brain.”
Contact us
Leodicum started between Liège and Silicon Valley. We’re now connecting business angels from Europe to start-ups in global tech hubs across the United States and Europe.
If you’re a founder looking to make a positive impact in the world, or an experienced entrepreneur or business angel looking to support projects that will make the world a better place, reach out.